AdaptHealth Corp. Net Income (Loss) Available to Common Stockholders, Diluted
AdaptHealth Corp. (AHCO) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$16.04 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-05-05
- AdaptHealth Corp. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was -$16.04M.
- AdaptHealth Corp. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$100.08M, a 317.56% decline year-over-year.
- AdaptHealth Corp. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $22.45M, a 7.29% increase year-over-year.
- AdaptHealth Corp. net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was $13.44M, a 24.41% decline year-over-year.
- AdaptHealth Corp. net income (loss) available to common stockholders, diluted for fiscal 2025 was -$70.79M, a 185.55% decline from fiscal 2024.
- AdaptHealth Corp. net income (loss) available to common stockholders, diluted for fiscal 2024 was $82.75M.
- AdaptHealth Corp. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$713.38M, a 1641.07% decline from fiscal 2022.
- AdaptHealth Corp. net income (loss) available to common stockholders, diluted for fiscal 2022 was $46.29M, a 47.76% decline from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$16.04M 10-Q · filed 2026-05-05 | -$116.12M derived: sum of 2 quarters · filed 2026-05-05 | -$93.67M derived: sum of 3 quarters · filed 2026-05-05 | -$80.23M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | -$100.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$77.63M derived: sum of 2 quarters · filed 2026-02-24 | -$64.19M derived: sum of 3 quarters · filed 2026-02-24 | -$70.79M 10-K · filed 2026-02-24 |
| 2025-09-30 | $22.45M 10-Q · filed 2025-11-04 | $35.89M derived: sum of 2 quarters · filed 2025-11-04 | $29.29M 10-Q · filed 2025-11-04 | $74.69M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-06-30 | $13.44M 10-Q · filed 2025-08-05 | $6.84M 10-Q · filed 2025-08-05 | $52.23M derived: sum of 3 quarters · filed 2026-05-05 | $73.16M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-03-31 | -$7.21M 10-Q · filed 2026-05-05 | $38.80M derived: sum of 2 quarters · filed 2026-05-05 | $59.72M derived: sum of 3 quarters · filed 2026-05-05 | $77.50M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $66.93M derived: sum of 2 quarters · filed 2026-02-24 | $84.71M derived: sum of 3 quarters · filed 2026-02-24 | $82.75M 10-K · filed 2026-02-24 |
| 2024-09-30 | $20.93M 10-Q · filed 2025-11-04 | $38.70M derived: sum of 2 quarters · filed 2025-11-04 | $36.74M 10-Q · filed 2025-11-04 | -$220.53M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $17.78M 10-Q · filed 2025-08-05 | $15.83M 10-Q · filed 2025-08-05 | -$241.45M derived: sum of 3 quarters · filed 2026-02-24 | -$704.69M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$2.13M 10-Q · filed 2025-05-06 | -$259.23M derived: sum of 2 quarters · filed 2026-02-24 | -$722.47M derived: sum of 3 quarters · filed 2026-02-24 | -$709.67M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$257.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$720.34M derived: sum of 2 quarters · filed 2026-02-24 | -$707.54M derived: sum of 3 quarters · filed 2026-02-24 | -$713.38M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$463.24M 10-Q · filed 2024-11-05 | -$450.44M derived: sum of 2 quarters · filed 2024-11-05 | -$456.28M 10-Q · filed 2024-11-05 | -$460.36M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $12.79M 10-Q · filed 2024-08-06 | $4.45M 10-Q · filed 2024-08-06 | $2.87M derived: sum of 3 quarters · filed 2025-02-25 | $17.63M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$7.53M 10-Q · filed 2024-05-07 | -$9.92M derived: sum of 2 quarters · filed 2025-02-25 | $4.84M derived: sum of 3 quarters · filed 2025-02-25 | $17.68M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $12.37M derived: sum of 2 quarters · filed 2025-02-25 | $25.22M derived: sum of 3 quarters · filed 2025-02-25 | $46.29M 10-K · filed 2025-02-25 |
| 2022-09-30 | $14.76M 10-Q · filed 2023-11-07 | $27.61M derived: sum of 2 quarters · filed 2023-11-07 | $48.68M 10-Q · filed 2023-11-07 | $92.14M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $12.85M 10-Q · filed 2023-08-08 | $32.55M 10-Q · filed 2023-08-08 | $77.37M derived: sum of 3 quarters · filed 2024-02-27 | $105.58M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $11.50M 10-Q · filed 2023-05-09 | $64.53M derived: sum of 2 quarters · filed 2024-02-27 | $92.73M derived: sum of 3 quarters · filed 2024-02-27 | $109.12M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $53.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $81.24M derived: sum of 2 quarters · filed 2024-02-27 | $97.63M derived: sum of 3 quarters · filed 2024-02-27 | $88.61M 10-K · filed 2024-02-27 |
| 2021-09-30 | $28.21M 10-Q · filed 2022-11-08 | $44.60M derived: sum of 2 quarters · filed 2022-11-08 | $35.58M 10-Q · filed 2022-11-08 | -$45.02M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $16.39M 10-Q · filed 2022-08-09 | $7.10M 10-Q · filed 2022-08-09 | -$73.23M derived: sum of 3 quarters · filed 2023-02-28 | -$124.26M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$9.10M 10-Q · filed 2022-05-10 | -$89.61M derived: sum of 2 quarters · filed 2023-02-28 | -$140.65M derived: sum of 3 quarters · filed 2023-02-28 | -$137.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$80.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$131.55M derived: sum of 2 quarters · filed 2023-02-28 | -$127.90M derived: sum of 3 quarters · filed 2023-02-28 | -$161.63M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$51.03M 10-Q · filed 2021-11-09 | -$47.38M derived: sum of 2 quarters · filed 2021-11-09 | -$81.12M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $3.65M 10-Q · filed 2021-08-06 | -$30.08M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | -$34.55M 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | -$21.34M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| CHEMED CORP (CHE) | United States | $6.474B | 22.14 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |